Replies to post #47 on Acer Therapeutics Inc (fka ACER)

[J-Belfort]

When the trial data comes out, all will benefit.

I do not believe RLF's interest is in ACERs drug for the maple syrup urine condition, there is an underlying motive imo.

I do know shares of ACER are limited, many dropped BRPA to move to ACER and more will follow soon.

Regardless, we must wait patiently and find out. Just holding

Best,
JB